Cutaneous immune related adverse events (cirAEs) are a common toxicity due to immune checkpoint inhibitors (ICI) to treat cancer. We provide a case series of 10 patients who presented with… Click to show full abstract
Cutaneous immune related adverse events (cirAEs) are a common toxicity due to immune checkpoint inhibitors (ICI) to treat cancer. We provide a case series of 10 patients who presented with low severity cirAEs who had their ICI discontinued against published guidelines and elucidate methods to decrease the risk of this occurrence.
               
Click one of the above tabs to view related content.